These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21904790)

  • 21. Neural stem/progenitor cells differentiate into oligodendrocytes, reduce inflammation, and ameliorate learning deficits after transplantation in a mouse model of traumatic brain injury.
    Koutsoudaki PN; Papastefanaki F; Stamatakis A; Kouroupi G; Xingi E; Stylianopoulou F; Matsas R
    Glia; 2016 May; 64(5):763-79. PubMed ID: 26712314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical Analysis of Fetal Human Mesencephalic Neural Progenitor Cell Lines: Characterization and Safety In Vitro and In Vivo.
    Moon J; Schwarz SC; Lee HS; Kang JM; Lee YE; Kim B; Sung MY; Höglinger G; Wegner F; Kim JS; Chung HM; Chang SW; Cha KY; Kim KS; Schwarz J
    Stem Cells Transl Med; 2017 Feb; 6(2):576-588. PubMed ID: 28191758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hematopoietic stem cell transplant for lysosomal storage diseases.
    Lund TC
    Pediatr Endocrinol Rev; 2013 Nov; 11 Suppl 1():91-8. PubMed ID: 24380127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stem cells as a potential therapy for epilepsy.
    Roper SN; Steindler DA
    Exp Neurol; 2013 Jun; 244():59-66. PubMed ID: 22265818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetically-modified hematopoietic stem cells and their progeny for widespread and efficient protein delivery to diseased sites: the case of lysosomal storage disorders.
    Biffi A
    Curr Gene Ther; 2012 Oct; 12(5):381-8. PubMed ID: 22934618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic approaches to lysosomal storage diseases.
    Kaye EM
    Curr Opin Pediatr; 1995 Dec; 7(6):650-4. PubMed ID: 8776014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human neural stem cells genetically modified for brain repair in neurological disorders.
    Kim SU
    Neuropathology; 2004 Sep; 24(3):159-71. PubMed ID: 15484694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adult neural stem cells: response to stroke injury and potential for therapeutic applications.
    Barkho BZ; Zhao X
    Curr Stem Cell Res Ther; 2011 Dec; 6(4):327-38. PubMed ID: 21466483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective Ablation of Tumorigenic Cells Following Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in Spinal Cord Injury.
    Kojima K; Miyoshi H; Nagoshi N; Kohyama J; Itakura G; Kawabata S; Ozaki M; Iida T; Sugai K; Ito S; Fukuzawa R; Yasutake K; Renault-Mihara F; Shibata S; Matsumoto M; Nakamura M; Okano H
    Stem Cells Transl Med; 2019 Mar; 8(3):260-270. PubMed ID: 30485733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stem cell transplantation for neurometabolic and neurodegenerative diseases.
    Shihabuddin LS; Aubert I
    Neuropharmacology; 2010 May; 58(6):845-54. PubMed ID: 20036262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delivering Hematopoietic Stem Cell Gene Therapy Treatments for Neurological Lysosomal Diseases.
    Holley RJ; Wood SR; Bigger BW
    ACS Chem Neurosci; 2019 Jan; 10(1):18-20. PubMed ID: 30136572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-stroke transplantation of adult subventricular zone derived neural progenitor cells--A comprehensive analysis of cell delivery routes and their underlying mechanisms.
    Doeppner TR; Kaltwasser B; Teli MK; Sanchez-Mendoza EH; Kilic E; Bähr M; Hermann DM
    Exp Neurol; 2015 Nov; 273():45-56. PubMed ID: 26253224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain.
    Snyder EY; Taylor RM; Wolfe JH
    Nature; 1995 Mar; 374(6520):367-70. PubMed ID: 7885477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Trials for Gene Therapy in Lysosomal Diseases With CNS Involvement.
    Sevin C; Deiva K
    Front Mol Biosci; 2021; 8():624988. PubMed ID: 34604300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different methods of immunosuppresion do not prolong the survival of human cord blood-derived neural stem cells transplanted into focal brain-injured immunocompetent rats.
    Jablonska A; Janowski M; Lukomska B
    Acta Neurobiol Exp (Wars); 2013; 73(1):88-101. PubMed ID: 23595286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transplantation of Stem Cells as a Potential Therapeutic Strategy in Neurodegenerative Disorders.
    Ebrahimi T; Abasi M; Seifar F; Eyvazi S; Hejazi MS; Tarhriz V; Montazersaheb S
    Curr Stem Cell Res Ther; 2021; 16(2):133-144. PubMed ID: 32598273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Astrocytes migrate from human neural stem cell grafts and functionally integrate into the injured rat spinal cord.
    Lien BV; Tuszynski MH; Lu P
    Exp Neurol; 2019 Apr; 314():46-57. PubMed ID: 30653967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell therapy for spinal cord injury by neural stem/progenitor cells derived from iPS/ES cells.
    Tsuji O; Miura K; Fujiyoshi K; Momoshima S; Nakamura M; Okano H
    Neurotherapeutics; 2011 Oct; 8(4):668-76. PubMed ID: 21909829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetically engineered human neural stem cells for brain repair in neurological diseases.
    Kim SU
    Brain Dev; 2007 May; 29(4):193-201. PubMed ID: 17303360
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.